Skin Cancer

4 protocols meet the specified criteria
Disease Site: Skin
Protocol No. Title
OCR13631 Molecular Analysis for Therapy Choice (MATCH)
OCR15092 An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors
OCR16626 A randomized, Investigator-and patient-blind, placebo-controlled, parallel group first in human and proof of concept study to evaluate the safety, tolerability, and efficacy of CLL442 in patients with Cutaneous Squamous Cell arcinoma in situ (SCCis)
OCR16937 A Phase 1 Study of NLG802 for Adult Patients with Recurrent Advanced Solid Tumors